Market Cap 564.75M
Revenue (ttm) 294.28M
Net Income (ttm) 367.02M
EPS (ttm) N/A
PE Ratio 4.69
Forward PE 7.18
Profit Margin 124.72%
Debt to Equity Ratio 0.06
Volume 265,100
Avg Vol 365,180
Day's Range N/A - N/A
Shares Out 18.48M
Stochastic %K 5%
Beta 1.27
Analysts Sell
Price Target $51.20

Company Profile

Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; REZLIDHIA, a non-intensive monotherapy to treat adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (I...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 624 1100
Fax: 650 624 1101
Address:
611 Gateway Boulevard, Suite 900, South San Francisco, United States
nirok
nirok Apr. 30 at 4:04 PM
$RIGL someone just paid 1milion to buy in
0 · Reply
DBales26
DBales26 Apr. 30 at 2:06 PM
$RIGL Right? And yet the Board of Directors still recommend him as a "For" in the proxy materials to get shareholders to vote in favor of him getting re-elected and clearly remaining as CEO. I can't understand how shareholders don't vote him out unless there's something going on behind the scenes. Or Raul has immunity based on his background or he has something on the company.
1 · Reply
Namhguab
Namhguab Apr. 30 at 12:17 PM
$RIGL Raul better actually have a story and a plan for this ER. Companies aren’t getting away with simply good numbers right now. They need a story and one that’s believable. You’d think this old man would want to ride into the sunset and set himself up in retirement by getting his company elevated to the next level. Something better be working behind the scenes because so far that side of his leadership has failed miserably.
1 · Reply
GO_DAWGS
GO_DAWGS Apr. 30 at 6:25 AM
$RIGL 😂😂😂😂
0 · Reply
nirok
nirok Apr. 29 at 7:48 PM
$RIGL Average volume 347k. today trading around 187k,very low volume .
0 · Reply
nirok
nirok Apr. 29 at 7:05 PM
$RIGL we need some volume to lift us up.
0 · Reply
Namhguab
Namhguab Apr. 29 at 3:31 PM
$RIGL what a damn joke. This thing is more manipulated than the majority of stocks I have ever owned in my life. Incredible really what they do to it.
1 · Reply
DosGatos
DosGatos Apr. 29 at 3:13 PM
$RIGL Raul needs to look into some blue chews - dude just cant keep it up!
2 · Reply
nirok
nirok Apr. 29 at 2:59 PM
$RIGL down 4.5% on 60k what joke .they do this every time before reporting.
0 · Reply
christopher18
christopher18 Apr. 29 at 2:23 PM
$RIGL Is Raul retiring this summer? Please do..... I have had less stress with women than this stock and that says something considering how bad they are!
0 · Reply
Latest News on RIGL
Rigel Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 3, 2026, 4:30 PM EST - 2 months ago

Rigel Pharmaceuticals Earnings Call Transcript: Q4 2025


Rigel Appoints Michael P. Miller to the Board of Directors

Feb 3, 2026, 8:05 AM EST - 3 months ago

Rigel Appoints Michael P. Miller to the Board of Directors


Rigel Provides Business Update and 2026 Outlook

Jan 12, 2026, 8:05 AM EST - 3 months ago

Rigel Provides Business Update and 2026 Outlook


Rigel Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 6 months ago

Rigel Pharmaceuticals Earnings Call Transcript: Q3 2025


Rigel to Participate in Upcoming September Investor Conferences

Aug 26, 2025, 8:05 AM EDT - 8 months ago

Rigel to Participate in Upcoming September Investor Conferences


Overlooked Stock: RIGL Nearly Doubles Stock in August

Aug 15, 2025, 5:20 PM EDT - 9 months ago

Overlooked Stock: RIGL Nearly Doubles Stock in August


The Big 3: OPEN, RIGL, JOBY

Aug 15, 2025, 12:00 PM EDT - 9 months ago

The Big 3: OPEN, RIGL, JOBY

JOBY OPEN


Rigel Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 9 months ago

Rigel Pharmaceuticals Earnings Call Transcript: Q2 2025


Rigel Pharmaceuticals Earnings Call Transcript: Q1 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

Rigel Pharmaceuticals Earnings Call Transcript: Q1 2025


Rigel Appoints Mark W. Frohlich, M.D.

Mar 10, 2025, 8:05 AM EDT - 1 year ago

Rigel Appoints Mark W. Frohlich, M.D.


Rigel Pharmaceuticals Earnings Call Transcript: Q4 2024

Mar 4, 2025, 4:30 PM EST - 1 year ago

Rigel Pharmaceuticals Earnings Call Transcript: Q4 2024


Rigel Provides Business Update and 2025 Outlook

Jan 13, 2025, 8:05 AM EST - 1 year ago

Rigel Provides Business Update and 2025 Outlook


Rigel Pharmaceuticals Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Rigel Pharmaceuticals Earnings Call Transcript: Q3 2024


Rigel Pharmaceuticals Earnings Call Transcript: Q2 2024

Aug 6, 2024, 4:30 PM EDT - 1 year ago

Rigel Pharmaceuticals Earnings Call Transcript: Q2 2024


Rigel Announces Reverse Stock Split

Jun 25, 2024, 8:00 AM EDT - 2 years ago

Rigel Announces Reverse Stock Split


Rigel Pharmaceuticals Earnings Call Transcript: Q1 2024

May 7, 2024, 4:30 PM EDT - 2 years ago

Rigel Pharmaceuticals Earnings Call Transcript: Q1 2024


Rigel Pharmaceuticals Earnings Call Transcript: Q4 2023

Mar 5, 2024, 4:30 PM EST - 2 years ago

Rigel Pharmaceuticals Earnings Call Transcript: Q4 2023


Rigel Pharmaceuticals Earnings Call Transcript: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Rigel Pharmaceuticals Earnings Call Transcript: Q3 2023


Rigel Pharmaceuticals Earnings Call Transcript: Q2 2023

Aug 1, 2023, 4:30 PM EDT - 2 years ago

Rigel Pharmaceuticals Earnings Call Transcript: Q2 2023


Rigel Pharmaceuticals Earnings Call Transcript: Q1 2023

May 2, 2023, 4:30 PM EDT - 3 years ago

Rigel Pharmaceuticals Earnings Call Transcript: Q1 2023


Rigel Pharmaceuticals Earnings Call Transcript: Q4 2022

Mar 7, 2023, 4:30 PM EST - 3 years ago

Rigel Pharmaceuticals Earnings Call Transcript: Q4 2022


Rigel Pharmaceuticals Transcript: FDA Announcement

Dec 1, 2022, 6:30 PM EST - 3 years ago

Rigel Pharmaceuticals Transcript: FDA Announcement


Rigel Pharmaceuticals Earnings Call Transcript: Q3 2022

Nov 3, 2022, 6:28 AM EDT - 3 years ago

Rigel Pharmaceuticals Earnings Call Transcript: Q3 2022


Rigel Pharmaceuticals Earnings Call Transcript: Q2 2022

Aug 2, 2022, 8:30 AM EDT - 4 years ago

Rigel Pharmaceuticals Earnings Call Transcript: Q2 2022


Rigel Pharmaceuticals Transcript: Study Result

Jun 8, 2022, 8:00 AM EDT - 4 years ago

Rigel Pharmaceuticals Transcript: Study Result


Rigel Pharmaceuticals Earnings Call Transcript: Q1 2022

May 3, 2022, 4:30 PM EDT - 4 years ago

Rigel Pharmaceuticals Earnings Call Transcript: Q1 2022


nirok
nirok Apr. 30 at 4:04 PM
$RIGL someone just paid 1milion to buy in
0 · Reply
DBales26
DBales26 Apr. 30 at 2:06 PM
$RIGL Right? And yet the Board of Directors still recommend him as a "For" in the proxy materials to get shareholders to vote in favor of him getting re-elected and clearly remaining as CEO. I can't understand how shareholders don't vote him out unless there's something going on behind the scenes. Or Raul has immunity based on his background or he has something on the company.
1 · Reply
Namhguab
Namhguab Apr. 30 at 12:17 PM
$RIGL Raul better actually have a story and a plan for this ER. Companies aren’t getting away with simply good numbers right now. They need a story and one that’s believable. You’d think this old man would want to ride into the sunset and set himself up in retirement by getting his company elevated to the next level. Something better be working behind the scenes because so far that side of his leadership has failed miserably.
1 · Reply
GO_DAWGS
GO_DAWGS Apr. 30 at 6:25 AM
$RIGL 😂😂😂😂
0 · Reply
nirok
nirok Apr. 29 at 7:48 PM
$RIGL Average volume 347k. today trading around 187k,very low volume .
0 · Reply
nirok
nirok Apr. 29 at 7:05 PM
$RIGL we need some volume to lift us up.
0 · Reply
Namhguab
Namhguab Apr. 29 at 3:31 PM
$RIGL what a damn joke. This thing is more manipulated than the majority of stocks I have ever owned in my life. Incredible really what they do to it.
1 · Reply
DosGatos
DosGatos Apr. 29 at 3:13 PM
$RIGL Raul needs to look into some blue chews - dude just cant keep it up!
2 · Reply
nirok
nirok Apr. 29 at 2:59 PM
$RIGL down 4.5% on 60k what joke .they do this every time before reporting.
0 · Reply
christopher18
christopher18 Apr. 29 at 2:23 PM
$RIGL Is Raul retiring this summer? Please do..... I have had less stress with women than this stock and that says something considering how bad they are!
0 · Reply
GO_DAWGS
GO_DAWGS Apr. 29 at 2:21 PM
$RIGL 😂😂😂😂
0 · Reply
Namhguab
Namhguab Apr. 29 at 1:43 PM
$RIGL stupidity once again
1 · Reply
christopher18
christopher18 Apr. 29 at 12:52 AM
$RIGL 60 cent drop to end the day..... Crazy!
1 · Reply
B4I4QQTRU18
B4I4QQTRU18 Apr. 28 at 6:01 PM
$RIGL Sanofi's Q1 results are out. Wayrilz competitor to Fost only sold 10 M euros globally. Still not really threatening Fost. We should still see growth in Fost. I am guessing they are having better sales in Europe where Rigel's partner is very lame. Slide 6. https://www.sanofi.com/assets/dotcom/content-app/events/quaterly-results/2026/2026-q1-2026-results/sanofi-q1-2026-results.pdf
2 · Reply
Gabriel1234
Gabriel1234 Apr. 28 at 5:51 PM
$RIGL https://www.zacks.com/stock/news/2909619/rigel-pharmaceuticals-rigl-to-report-q1-results-wall-street-expects-earnings-growth?cid=CS-MKTWTCH-HL-tale_of_the_tape|yseop_template_9-2909619&mod=mw_quote_news
0 · Reply
B4I4QQTRU18
B4I4QQTRU18 Apr. 28 at 2:42 PM
$RIGL 4.4 million share short at 31 is roughly 136 million interest free loan to buy chips. Can get a little rotation here please. Don’t let them use Rigel as a “Heloc” Raul.
0 · Reply
B4I4QQTRU18
B4I4QQTRU18 Apr. 28 at 2:37 PM
$RIGL relentless! 200k volume yesterday it is still getting shorted and bought.
1 · Reply
B4I4QQTRU18
B4I4QQTRU18 Apr. 28 at 12:07 AM
$RIGL volume 200k today. To cover 4.2 million low float is basically a month at this volume. Seems this is just primed for a big fat squeeze.
3 · Reply
Sage_the_Sage
Sage_the_Sage Apr. 27 at 4:59 PM
$RIGL So why is there 24% short interest? Expenses will ramp up for R289? (Q4 was 46M) They think earnings will disappoint? If nothing else, the Company's guidance has been spot-on and we've seen that it has good visibility there. They tend to be at the high end or slightly above guidance, which is what you want. The bad news on Lilly is in the past, and frankly, Rigel never expected another dime from there....look at all their earnings presentations and guidances. There won't be any new info on R289 until much later in 2026. P/E ratio is way too low. I expect a solid quarter (albeit with possible Q1 seasonal blip) and we should see more interest from value funds. Will be fun to see what the shorts do with a little buying pressure. Look at what happened to Avis.
1 · Reply
Sage_the_Sage
Sage_the_Sage Apr. 27 at 4:43 PM
$RIGL Using Rigel's guidance, I see the full year coming in at about $100M in pre-tax earnings. Raul pointed out that the Company will still have some growth 26/25 even though 25 was such a transformative year. But assume a nice steady-state (i.e., no new product acquisition, nothing coming out on R289), and what do you think a fair PE ratio is? Even at 12, that's more than double the current market cap.
1 · Reply
Purplesabbath
Purplesabbath Apr. 27 at 3:22 PM
$RIGL Lilly buys yet ANOTHER company. Meanwhile they strung Rigl along for how many years for chump change?
2 · Reply
B4I4QQTRU18
B4I4QQTRU18 Apr. 27 at 3:21 PM
$RIGL it will probably rise all week going into earnings next week. Will Raul make up a BS slide or give something of substance. New deal, share buy back, better than expected growth, raised guidance, … Strong cash position now!
0 · Reply